Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer—Results of the prospective multicenter PERMAD trial. - Seufferlein, Thomas; Lausser, Ludwig; Stein, Alexander; Arnold, Dirk; Prager, Gerald; Kasper-Virchow, Stefan; Niedermeier, Michael; Müller, Lothar; Kubicka, Stefan; König, Alexander; Büchner-Steudel, Petra; Wille, Kai; et al. (PLoS ONE, 2024)